---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-279577"
form_type: "8-K"
ticker: "SLN"
cik: "0001479615"
company_name: "Silence Therapeutics plc"
filed_at: "2026-06-23T20:35:22+00:00"
generated_at: "2026-06-23T20:37:06.840596+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Silence Therapeutics issues updated corporate presentation on June 23, 2026

## Summary
- Updated corporate presentation posted to investor section of company website.
- Presentation contains business updates but no specific financial or clinical data disclosed.
- Filing under Item 7.01; presentation furnished as Exhibit 99.1.
- No material new information provided in the 8-K itself.

## SEC filing metadata
- accession: 0001193125-26-279577
- form_type: 8-K
- ticker: SLN
- cik: 0001479615
- company_name: Silence Therapeutics plc
- filed_at: 2026-06-23T20:35:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479615/000119312526279577/0001193125-26-279577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479615/000119312526279577/sln-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-279577
- JSON: https://secwatch.observer/filing/0001193125-26-279577.json
- Plain text: https://secwatch.observer/filing/0001193125-26-279577.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.